Biz Journal

An experimental Covid-19 vaccine from Novavax Inc. was 90.4% efficient at stopping symptomatic illness in adults in a big medical trial, the corporate stated, outcomes that transfer the shot a step nearer to international use.

The 29,960-person examine carried out within the U.S. and Mexico additionally discovered that the vaccine was equally efficient in opposition to newer coronavirus strains, particularly the alpha variant now dominant within the U.S., Novavax stated.

The vaccine, given in two doses three weeks aside, was additionally usually secure and properly tolerated within the examine, the corporate stated.

“Our vaccine works very properly although the virus has mutated considerably,” stated Dr. Gregory Glenn, Novavax’s president of analysis and improvement.

Altogether, the outcomes counsel Novavax’s vaccine is on monitor to turn out to be the fourth approved to be used within the U.S. But Novavax executives stated the regulatory clearances are months away as a result of

Think about this office situation: Because the pandemic recedes, workers in Firm X are given the choice of returning to the workplace or working remotely. Mary decides to return to the house workplace in New York. Her former workplace mate, John, decides to stay in Omaha, Neb., the place he has been residing for the reason that pandemic started.

They’ve the identical titles and the identical obligations. Ought to in addition they have the identical pay?

That is only one of many compensation points firms are prone to wrestle with in coming months, as companies reimagine how you can pay and reward workers in a world the place some employees could not return to the workplace.

“The distant workforce is right here to remain,” says Susan Schroeder, a companion at Compensation Advisory Companions, a nationwide compensation consulting agency with places of work in New York, Houston, Chicago and Los Angeles.